Sign in
4

Changes in Ownership

Cardiff Oncology, Inc. Filed Acc 0001104659-20-075240

Options or other derivatives

  • Director acquired 28,858 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
White Lale Director 2020-06-17 Grant or award · Stock Options +28,858 40,774 D: show line 1 in the form
Loading xslF345X03/a4.xml…